Results of the Phase III DASISION trial and the future of CML treatment
Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202
Combining venetoclax and obinutuzumab in the treatment of CLL
What does the CLL forum data tell us?
Where are we with precision medicine for CLL?